Skip to main content
IMV Inc. logo

IMV Inc. — Investor Relations & Filings

Ticker · IMV ISIN · CA44974L3011 TSX Professional, scientific and technical activities
Open in API
Filings indexed 216 across all filing types
Latest filing 2023-05-08 Delisting Announcement
Country CA Canada
Listing TSX IMV

About IMV Inc.

http://imv-inc.com/

IMV Inc. is a clinical-stage biopharmaceutical company specializing in immuno-oncology. The company is pioneering a novel class of cancer immunotherapies and vaccines for infectious diseases, such as RSV and COVID-19. Its core unique selling proposition is the proprietary immune-educating platform, known as DPX® technology. This platform is designed to make immunotherapies more effective and broadly applicable across various therapeutic areas, including cancer therapy and infectious diseases. IMV aims to advance its portfolio of DPX-based therapies through clinical development.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Delisting Announcement Classification · 95% confidence The document is a media release announcing that IMV Inc. has received a delisting notice from Nasdaq due to its filing for creditor protection under the Companies' Creditors Arrangement Act and the subsequent suspension of trading and removal of its shares from Nasdaq. The text references regulatory rules and the filing of Form 25-NSE with the SEC to effect the delisting. There are no financial statements, detailed financial data, or comprehensive report content present. The document is an official notice about the delisting event, not a full report or financial filing. Therefore, it fits the category of a Delisting Announcement (DLST). The document length is moderate and contains detailed information about the delisting event, supporting a high confidence classification.
2023-05-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a media release announcing that IMV Inc. received a notification from Nasdaq regarding a minimum bid price deficiency. It discusses the compliance period and potential consequences related to Nasdaq listing rules. There is no detailed financial data, no full report, or comprehensive financial statements included. The document is an official announcement about a regulatory compliance issue related to stock listing, not a financial report or earnings release. It fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about compliance with listing requirements.
2023-03-31 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a media release announcing the upcoming announcement of the company's fourth quarter and fiscal year 2022 financial results and a conference call/webcast to discuss these results. It does not contain actual financial data or detailed financial statements but rather informs about the timing and access to the forthcoming earnings release and conference call. This fits the definition of an Earnings Release (ER) announcement, as it highlights the initial announcement of quarterly/fiscal year financial results and the related conference call. The document is about the announcement of results and the event, not the full report itself.
2023-03-09 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing positive initial results from a Phase 2B clinical trial (VITALIZE) conducted by IMV Inc. It provides preliminary efficacy and safety data, but does not contain comprehensive financial statements or detailed financial analysis. The content focuses on clinical trial progress and early data rather than quarterly or annual financial results. It is not a full earnings release, annual report, or interim report. The document is a corporate announcement about clinical trial results, which fits best under the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit other specific categories like earnings release or investor presentation. The document length (7557 characters) and content confirm it is not a brief report publication announcement or a certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-02-13 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a corporate announcement detailing updates on clinical development milestones, recent financing completion, and a board appointment. It includes preliminary unaudited financial results but does not contain comprehensive financial statements or detailed financial analysis. The document also mentions the appointment of a new board member and retirement of an existing one. The content is typical of a corporate update or press release rather than a formal financial report or regulatory filing. It does not fit the criteria for Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or Management Reports (MDA). It also is not a full transcript, audit report, or legal proceeding update. The key elements are a financing update and a board change announcement. However, the board change is a single appointment and retirement, which fits best under Board/Management Information (MANG). The financing update is mentioned but not detailed as a full financing report. Given the prominence of the board appointment and retirement, the best classification is Board/Management Information (MANG). Confidence is high due to clear mention of board changes and no full financial report included.
2023-01-09 English
Material document(s).pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'SECURITIES PURCHASE AGREEMENT' and details terms and conditions for the issuance and sale of securities by IMV Inc. It includes definitions, purchase and sale terms, closing conditions, and legal counsel opinions. This is a contract related to capital raising and financing activities, not a financial report, earnings release, or regulatory filing. It is a detailed agreement for a financing transaction, which fits the category of Capital/Financing Update filings.
2022-12-22 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.